🇺🇸 FDA
Patent

US 7112574

C2,8-disubstituted adenosine derivatives and their different uses

granted A61PA61P17/02A61P25/18

Quick answer

US patent 7112574 (C2,8-disubstituted adenosine derivatives and their different uses) held by CAN-FITE BIOPHARMA LTD. expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAN-FITE BIOPHARMA LTD.
Grant date
Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P17/02, A61P25/18, A61P25/28, A61P43/00